| Related Articles |
Receipt of Medication and Behavioral Therapy among a National Sample of School-Aged Children Diagnosed with ADHD.
Acad Pediatr. 2017 Oct 20;:
Authors: Walls M, Allen C, Cabral H, Kazis LE, Bair-Merritt M
Abstract
Objective In 2011, the American Academy of Pediatrics published practice guidelines for ADHD, recommending both medication and behavioral therapy for school-aged children. The current study examines associations between child/family characteristics and ADHD medication, behavioral, and combined therapy. Methods This study used data from the 2014 National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome, a nationally-representative follow-up survey to the 2011-2012 National Survey of Children’s Health. Descriptive statistics were used to estimate frequencies of ADHD treatments and multivariable logistic regression to examine child/family characteristics associated with parent-reported medication use, classroom management, and parent training for children ages 8 to 17 diagnosed with ADHD (n=2,401). Results Black and Hispanic children were less likely than white children to have ever taken ADHD medication. Hispanic children were less likely than white children to be currently taking medications (aOR: 0.49, 95% CI: 0.30-0.80). No differences were found in current medication use for black children when compared to white children. Thirty-percent of parents reported that their child was currently receiving classroom management and 31% reported having ever received parent training for ADHD. Children whose ADHD medication was managed by a primary care physician were less likely to receive combined medication and behavioral therapy when compared to children managed by specialty physicians (aOR: 2.58, 95% CI: 1.75-3.79). Conclusion Most school-aged children reported taking medication for ADHD, however, medication disparities persist. Parent-reported use of behavioral therapies are low. Future research should examine reasons for observed variation in treatment and interventions to optimize ADHD care.
PMID: 29061327 [PubMed – as supplied by publisher]
via https://www.ncbi.nlm.nih.gov/pubmed/29061327?dopt=Abstract
